<< Drug AMD-3100 may help cancer patients who need stem cell transplants | Methoxychlor (MXC), a common insect pesticide may lead to reduced fertility in women >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Dansk | Nederlands | Русский | Svenska | Polski

Making practical markets for vaccines

Published on September 19, 2005 at 5:41 AM · No Comments

Two papers published on September 13 in PLoS Medicine raise concerns about whether world leaders are getting good advice on how best to fund the development and delivery of new vaccines.

Donald Light, Professor of comparative health care systems at the University of Medicine & Dentistry of New Jersey, discusses the report Making Markets for Vaccines produced by the Centre for Global Development and the Gates Foundation Working Group for Making Markets for Vaccines. Professor Light was a member of the CGD/Gates Foundation "Pull" Mechanisms Working Group for the report but finding the report impractical, he declined to endorse it. For this, he and others who dissented were de-listed as members in the report.

In his essay, Professor Light explains why he thinks the report's recommendations give poor advice to donor nations such as the United States and the U.K. He believes that they favor large pharmaceutical firms, delay saving lives, spend donations wastefully, and reward secrecy rather than sharing.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading